Table 1:
Preoperative clinical and echocardiographic data
| Valve function | Age | Gender (M) | Sinuses (cm) | Sino-tubular (cm) | Ascending (cm) | Hypertension | Diabetes | COPD | CRF | |
|---|---|---|---|---|---|---|---|---|---|---|
| TAV (n = 87) | Normal (n = 36) | 66 ± 8 | 13 (36%) | 3.5 ± 0.4 | 3.4 ± 0.5 | 5.3 ± 0.6 | 29 (81%) | 2 (5.6%) | 7 (19%) | 2 (5.6%) |
| Stenosis (n = 12) | 61 ± 11 | 7 (58%) | 3.6 ± 0.6 | 3.4 ± 0.6 | 5.1 ± 0.5 | 8 (67%) | – | 2 (17%) | 1 (8.3%) | |
| Regurgitation (n = 39) | 66 ± 8 | 24 (61%) | 4.3 ± 0.7 | 4.2 ± 0.8 | 5.4 ± 0.9 | 31 (79%) | 2 (5.1%) | 11 (28%) | 5 (13%) | |
| P (TAV)a | 0.15 | 0.07 | <0.001* | <0.001* | 0.64 | 0.51 | 0.72 | 0.57 | 0.61 | |
| BAV (n = 69) | Normal (n = 10) | 51 ± 19 | 6 (60%) | 3.8 ± 0.3 | 3.7 ± 0.3 | 5.1 ± 0.4 | 5 (50%) | – | 2 (20%) | – |
| Stenosis (n = 37) | 60 ± 13 | 28 (76%) | 3.8 ± 0.9 | 3.4 ± 0.5 | 5.1 ± 0.6 | 17 (46%) | 3 (8.1%) | 6 (16%) | 1 (2.7%) | |
| Regurgitation (n = 22) | 54 ± 11 | 17 (77%) | 4.2 ± 0.6 | 3.9 ± 0.7 | 5.4 ± 1.3 | 14 (64%) | 4 (18%) | 3 (14%) | 2 (9.1%) | |
| P (BAV)a | 0.13 | 0.60 | 0.19 | 0.007* | 0.34 | 0.22 | 0.16 | 0.31 | 0.55 | |
| Overall | 62 ± 12 | (61%) | 3.9 ± 0.6 | 3.7 ± 0.7 | 5.3 ± 0.8 | 104 (67%) | 11 (7%) | 31 (20%) | 11 (7%) | |
| All TAV | 65 ± 9 | 44 (51%) | 3.9 ± 0.7 | 3.7 ± 0.8 | 5.3 ± 0.7 | 68 (78%) | 4 (4.6%) | 20 (23%) | 8 (9.2%) | |
| All BAV | 57 ± 14 | 51 (74%) | 3.9 ± 0.6 | 3.6 ± 0.6 | 5.2 ± 0.9 | 36 (52%) | 7 (10%) | 11 (16%) | 3 (4.3%) | |
| P (TAV versus BAV) | <0.001* | <0.001* | 0.002* | 0.65 | 0.33 | 0.43 | 0.001* | 0.21 | 0.11 | 0.22 |
All data are reported as count (percentage) or mean ± SD. BAV, bicuspid aortic valve; COPD, chronic obstructive pulmonary disease; CRF, chronic renal failure; TAV, tricuspid aortic valve.
aANOVA test between valve function subgroups.
*indicates statistical significance.